HAART to HAART: Current and Future Pharmacotherapies For HIV

ISSN： 1176-3469

Source： Pharmaceutical & Diagnostic Innovation, Vol.2, Iss.6, 2004-11, pp. : 17-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HAART in HIV/AIDS Treatments: Future Trends

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 18, Iss. 1, 2018-03 ,pp. : 15-22

Bentham Science Publishers

Access to resources Recommend Favorite

Cotrimoxazole then HAART pays off in Ugandan employees with HIV

Inpharma, Vol. 1, Iss. 1536, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Initiating HAART earlier a prudent move in HIV infections

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 489, 2005-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

HIV-1 rebound after HAART discontinuation examined

Inpharma, Vol. 1, Iss. 1249, 2000-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

HAART improves outcomes in patients with HIV-related HD

Inpharma, Vol. 1, Iss. 1364, 2002-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite